BridgeBio insider plans sale of 34,980 shares
BridgeBio Pharma, Inc. (BBIO) received a notice that Neil Kumar intends to sell common stock under Rule 144.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
BridgeBio Pharma, Inc. (BBIO) received a notice that Neil Kumar intends to sell common stock under Rule 144. The filing lists 34,980 shares of common stock held through Morgan Stanley Smith Barney, with a reported value of $2,794,552.20, against 195,487,474 shares outstanding as of August 18, 2026. It also details prior Rule 10b5-1 plan sales over the past three months by Kumar and related trusts.
Key Figures
Key Terms
Rule 144 regulatory
Restricted Stock Units financial
10b5-1 regulatory
Revocable Trust financial
Irrevocable Trust financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 144 filing by BBIO insider Neil Kumar disclose?
AI-generated analysis. How Rhea-AI works. Not financial advice.